Accelerated Barrier Repair in Human Skin Explants Induced with a Plant-Derived PPAR-α Activating Complex via Cooperative Interactions
George Majewski,John Craw,Timothy Falla
DOI: https://doi.org/10.2147/CCID.S325967
2021-09-18
Abstract:George Majewski, 1, 2 John Craw, 1 Timothy Falla 1 1 Rodan & Fields, San Francisco, CA, 94105, USA; 2 Present Affiliation: Contrast Product Development, Walnut, CA, 91789, USA Correspondence: John Craw Rodan & Fields, 60 Spear Street, Suite 600, San Francisco, CA, 94105, USA Email Background: Peroxisome proliferator-activated receptors (PPARs) govern epidermal lipid synthesis and metabolism. In skin, PPAR activation has been shown to regulate genes responsible for permeability barrier homeostasis, epidermal differentiation, lipid biosynthesis, and inflammation. Objective: Given the known dermatologic benefits of PPARs, we set out to discover a naturally derived, multi-molecule complex that would be superior to the more commonly formulated conjugated linoleic acids (CLAs). We hypothesized that a complex may be capable of modulating PPAR-α by cooperative or multi-ligand binding interactions to accelerate skin barrier repair. Methods: To achieve this, we assembled a novel PPAR-α agonist complex, referred to as RFV3, from a combination of small molecules routinely used in Ayurvedic medicine and accepted in cosmetic and topical over-the-counter dermatologic products. We tested RFV3's potential as a PPAR-α agonist by evaluating its transcriptional response, ligand binding affinity to PPAR-α, gene expression profiles and barrier repair properties in human skin explant models. Results: We assembled RFV3 by solubilizing two standardized plant extracts in a suitable solvent and induced a significant transcriptional response in PPAR-α luciferase reporter assay. Furthermore, transcriptome profiling of RFV3-treated epidermal substitutes revealed expressed genes consistent with known targets of PPAR-α, including those involved in epidermal barrier repair. In addition, in silico modeling demonstrated differential co-binding affinities of RFV3 to PPAR-α compared with those of the endogenous ligands (CLAs) and a synthetic PPAR-α agonist. Lastly, delipidated skin explant models confirmed accelerated barrier repair activity with significant increases in ceramides, filaggrin and transglutaminase-1 after treatment. Conclusion: These findings suggest that the RFV3 complex successfully mimics a PPAR-α agonist and induces synthesis of skin barrier lipids and proteins consistent with known PPAR pathways. Keywords: PPAR-α, cooperative binding, epidermal barrier, explants, ceramides Nuclear receptors (NRs) are ligand-binding transcription factors that sense the cellular environment and subsequently reprogram gene expression in target tissues to coordinate the appropriate physiologic response. 1,2 Upon ligand binding, NRs translocate to the nucleus, heterodimerize to their binding partner and bind to NR response elements to regulate the transcription of target genes. 3 The peroxisome proliferator-activated receptor (PPAR) family of NRs are activated by lipid metabolites and regulate a wide variety of lipid-related genes. 4 There are three known PPAR isotypes: PPAR-α, PPAR-β/δ, and PPAR-γ. Although they share considerable sequence and structural homology, their tissue distribution, ligand specificity, and physiologic responses to ligands are unique to each isotype. All three isotypes play important roles in skin homeostasis and have been identified in different skin cell types and expressed in keratinocytes, hair follicle epithelial cells, melanocytes, immature epidermal Langerhans cells, basal and differentiated sebocytes, and cutaneous immune cells. 5–21 The pivotal role of PPAR signaling in the skin has been highlighted in a multitude of studies. PPAR-α activators induce keratinocyte differentiation and epidermal lipid synthesis, including ceramide production, thus accelerating the morphologic and functional maturation of the epidermal permeability barrier. 22–27 The epidermal barrier (EB) is localized to the outermost layer of the epidermis, the stratum corneum (SC), and maintains water content, electrolyte balance and prevents dehydration. 28 The proper functioning of the EB is greatly dependent on the structure and composition of the SC. The SC is comprised of anucleated terminally differentiated keratinocytes embedded in a lamellar lipid matrix and provides a barrier to the movement of water and electrolytes. As keratinocytes differentiate to form the SC, they sequentially express specific proteins including keratins, filaggrin, transglutaminase, involucrin and loricrin that serve as important structural scaffolds for the extracellular lipid matrix. 29–32 Moreover, these proteins are also targets of PPAR activation. 5–31 In addition, the differentiating keratinocytes s -Abstract Truncated-